Literature DB >> 11168338

Concordance between fasting and 2-h post-glucose challenge criteria for the diagnosis of diabetes mellitus and glucose intolerance in high risk individuals.

J Drzewoski1, L Czupryniak.   

Abstract

AIMS: To compare the new fasting with the 2-h post glucose challenge diagnostic criteria for diabetes mellitus in a high-risk Central European population.
METHODS: The results of the 75-g oral glucose tolerance tests (OGTT) performed between 1st January 1990 and 31st December 1998 in patients at high risk of glucose metabolism disturbance were analysed.
RESULTS: From 1554 patients with OGTT results available for the study, 1360 (759 women and 601 men, aged 65.5+/-6.9 years, body mass index 28.2 +/- 4.5 kg/m2) were included into the study. With the use of the post-challenge criteria, 41.3% of the analysed population had diabetes or impaired diabetes tolerance (IGT), whereas with the new fasting system only 16.6% would have been diagnosed with any type of glucose intolerance. Diabetes was significantly more often diagnosed with the post-challenge criteria than with the fasting ones: 16.2 vs. 5.3% (P < 0.0001). The subjects with diabetes diagnosed upon fasting glucose value were significantly younger than the subjects with diabetes diagnosed according to the 2-h glucose challenge: 65.7 +/- 6.2 vs. 68.8 +/- 7.0 years, respectively (P < 0.01). The sensitivity of the new criteria for the diagnosis of diabetes was 18.2%, and specificity 97.2%. A total of 77.8% of IGT cases would have been diagnosed as having normal glucose metabolism according to the fasting glucose. The sensitivity of the new criteria for the diagnosis of impaired glucose tolerance (IGT or impaired fasting glucose) was 14.6%, and specificity 89.8%. The overall kappa statistic (k) was low; 0.211 (95% confidence interval 0.149-0.27).
CONCLUSIONS: The new lower fasting criteria might be too insensitive to identify a large proportion of individuals with diabetes or impaired glucose intolerance, particularly in a high-risk population.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11168338     DOI: 10.1046/j.1464-5491.2001.00403.x

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  6 in total

1.  Diagnostic difficulties in long-standing insulinoma with near-normal plasma insulin levels.

Authors:  L Czupryniak; J Strzelczyk; J Drzewoski
Journal:  J Endocrinol Invest       Date:  2005-02       Impact factor: 4.256

2.  Optimal Hemoglobin A1c Levels for Screening of Diabetes and Prediabetes in the Japanese Population.

Authors:  Masanori Shimodaira; Shinji Okaniwa; Norinao Hanyu; Tomohiro Nakayama
Journal:  J Diabetes Res       Date:  2015-05-31       Impact factor: 4.011

3.  Determinants of lifestyle behavior change to prevent type 2 diabetes in high-risk individuals.

Authors:  N R den Braver; E de Vet; G Duijzer; J Ter Beek; S C Jansen; G J Hiddink; E J M Feskens; A Haveman-Nies
Journal:  Int J Behav Nutr Phys Act       Date:  2017-06-12       Impact factor: 6.457

4.  Performance of an A1C and fasting capillary blood glucose test for screening newly diagnosed diabetes and pre-diabetes defined by an oral glucose tolerance test in Qingdao, China.

Authors:  Xianghai Zhou; Zengchang Pang; Weiguo Gao; Shaojie Wang; Lei Zhang; Feng Ning; Qing Qiao
Journal:  Diabetes Care       Date:  2009-12-10       Impact factor: 19.112

5.  Using Serum Advanced Glycation End Products-Peptides to Improve the Efficacy of World Health Organization Fasting Plasma Glucose Criterion in Screening for Diabetes in High-Risk Chinese Subjects.

Authors:  Zilin Sun; Jiajia He; Shanhu Qiu; Chenghao Lei; Yi Zhou; Zuolin Xie; Lin Zhang; Yanping Wang; Hui Jin
Journal:  PLoS One       Date:  2015-09-14       Impact factor: 3.240

6.  Detecting Prediabetes and Diabetes: Agreement between Fasting Plasma Glucose and Oral Glucose Tolerance Test in Thai Adults.

Authors:  Wichai Aekplakorn; Valla Tantayotai; Sakawduan Numsangkul; Wilarwan Sripho; Nutchanat Tatsato; Tuanjai Burapasiriwat; Rachada Pipatsart; Premsuree Sansom; Pranee Luckanajantachote; Pongpat Chawarokorn; Anek Thanonghan; Watchira Lakhamkaew; Aungsumalin Mungkung; Rungnapa Boonkean; Chanidsa Chantapoon; Mayuree Kungsri; Kasetsak Luanseng; Kornsinun Chaiyajit
Journal:  J Diabetes Res       Date:  2015-08-06       Impact factor: 4.011

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.